Alterations in HA metabolism induced by silencing HAS3, blocking its binding with the receptor CD44, or administering 4-MU inhibited autophagy flux, arrested the cell cycle at G1 phase, and subsequently inhibited glioma cell proliferation in the present study. This evidence concerns the gene HAS3 and central nervous system cancer.